WeVote
Log In

Bill

Bill

SB 805

Relating to abortion pill reversal

2026 Regular Session Introduced by Kevan Bartlett and 5 co-sponsors

Establishes or regulates abortion pill reversal options in West Virginia, including patient education, provider standards, and possible funding or reporting requirements.

To House Finance
#humanservices
0
WeVote Research Nonpartisan
Bill Summary · SB 805

Executive summary

SB 805, introduced in the West Virginia Senate in 2026, concerns abortion pill reversal. The bill's text is not provided here, but the legislative history indicates it passed the Senate and advanced to the House for consideration, with a focus on abortion-pill reversal provisions. The sponsor lineup includes multiple co-sponsors, signaling bipartisan or broad interest. The bill underwent standard committee review, including a Finance committee due to potential fiscal implications.

What the bill aims to address

  • The primary subject is abortion pill reversal, a process by which certain medical interventions are claimed to reverse the effects of a medication used to induce abortion.
  • The bill would establish, clarify, or regulate state-level policy surrounding abortion pill reversal within West Virginia.

Key provisions and changes (as typically associated with this topic)

Note: The exact statutory language is not provided here. Based on the bill’s title and the standard regulatory framework for abortion-pill reversal in state legislatures, potential provisions may include:
- Establishment or recognition of abortion pill reversal as a medical option or mandated information in certain clinical settings.
- Requirements for informed consent or patient education regarding abortion pills and reversal options.
- Standards for health care providers offering reversal treatment, including qualifications, protocols, and recordkeeping.
- Funding or insurance-related provisions to cover reversal services (if any), or appropriation measures directed through the state budget.
- Reporting or oversight mechanisms to track utilization, outcomes, and safety data.
- Limitations or protections related to abortion restrictions, counseling, or referrals tied to reversal information.
- Conflict-of-law or conformity with federal and state medical practice laws.

Because the bill moved through Finance and Health and Human Resources committees and offices, it likely includes:
- A fiscal impact assessment (costs of implementing information campaigns, provider training, or data collection).
- Potential administrative rules, reporting requirements, or regulatory guidance for health facilities and practitioners.

Who would be affected

  • Pregnant individuals seeking abortion care in West Virginia and those considering reversal of an abortion pill.
  • Health care providers (clinics, physicians, nurse practitioners, pharmacists) who administer, prescribe, counsel, or provide reversal-related services.
  • State health agencies and licensed health facilities responsible for compliance, reporting, and data collection.
  • Payers, including state Medicaid programs or private insurers, if there are any provisions affecting coverage or information requirements.
  • The general public, through potential education or notification requirements about reversal options.

Procedural and timeline aspects

  • Introduction and initial referral: Filed February 6, 2026; assigned to Health and Human Resources, then Finance.
  • Senate committee action: Reported do pass on February 27, 2026; committee substitute reported on February 20, 2026 (to Finance).
  • Senate advancement: Passed the Senate on March 4, 2026 (Roll No. 343); ordered to the House.
  • House actions: Referred to House Health and Human Resources, then Finance; markup discussions occurred March 10, with a “Do pass, but first to Finance” action on March 11, 2026.
  • Next steps: If the House approves, the bill would return to the Senate for concurrence or be enrolled for the governor’s signature. Timelines depend on floor action and budgetary considerations indicated by the Finance committee.

Public considerations

  • The bill engages with contested medical and ethical questions surrounding abortion and reversal therapies.
  • It may influence patient information standards, provider practices, and potential state-funding or insurance requirements.
  • Stakeholders may include medical associations, patient advocacy groups on both sides of abortion policy, and health care administrators.

If you would like, I can tailor this summary to include hypothetical but plausible text once the actual bill language is available, or extract and annotate specific provisions, fiscal notes, and timelines from the bill’s official documents.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.